Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.
Kari Oakes, PA-C
Advertisement
Articles by Kari Oakes, PA-C
Advertisement
Latest Updated Articles
- Tenofovir Plus Interferon Improves Antigen Clearance in Chronic Hepatitis B
Published: December 13th 2014 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Clinical Takeaways From ViiV’s PASO DOBLE and CLARITY Studies
2
Phage and Antibiotic Combination Therapy for Biofilm-Associated Bacterial Infections
3
Maldives Validated by WHO as First Country to Achieve Triple EMTCT of HIV, Syphilis, and Hepatitis B
4
Streamlining IV-to-Oral Transitions in Pneumonia Care: Duration, Tailoring, and Post-Discharge Considerations
5
